Goodbody Health Limited carries a market capitalization of 365.00, placing it among publicly traded companies globally. Its enterprise value stands at -2.41M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 365.00 |
| Enterprise Value | -2.41M |
Goodbody Health Limited currently has 36.50M shares outstanding.
| Shares Outstanding | 36.50M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.03, and the price-to-book ratio stands at 0.98.
| PE Ratio | N/A |
| PS Ratio | 0.03 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 0.11 |
| P/FCF Ratio | -1.26 |
| P/OCF Ratio | -0.75 |
On an enterprise value basis, Goodbody Health Limited trades at an EV/EBITDA multiple of 18.25 and an EV/FCF ratio of 9.93.
| EV / Sales | 1.02 |
| EV / EBITDA | 18.25 |
| EV / EBIT | N/A |
| EV / FCF | 9.93 |
Goodbody Health Limited maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.25 |
| Quick Ratio | 1.86 |
| Debt / Equity | 2.55 |
| Debt / EBITDA | -0.11 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | -148.93 |
| Return on Assets (ROA) | -41.97 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 14.11 |
| Income Tax | 67,634.00 |
| Effective Tax Rate | N/A |
Over the trailing twelve months, Goodbody Health Limited generated 16.47M in revenue and converted that into -3.72M in net income, yielding earnings per share of -0.10. EBITDA reached -1.22M, while operating income came in at -1.88M.
| Revenue | 16.47M |
| Gross Profit | 8.09M |
| Operating Income | -1.88M |
| Pretax Income | -3.66M |
| Net Income | -3.72M |
| EBITDA | -1.22M |
| EBIT | -1.88M |
| Earnings Per Share (EPS) | -0.10 |
Goodbody Health Limited holds 3.05M in cash and equivalents against 138,938.00 in total debt, resulting in a net debt position of -3.05M. Total book value stands at 516,455.00, with working capital of 2.18M providing operational flexibility.
| Cash & Cash Equivalents | 3.05M |
| Total Debt | 138,938.00 |
| Net Debt | -3.05M |
| Equity (Book Value) | 516,455.00 |
| Book Value Per Share | 0.01 |
| Working Capital | 2.18M |
Goodbody Health Limited produced -674,670.00 in operating cash flow over the past twelve months. After subtracting -272,616.00 in capital expenditures, free cash flow totaled -947,286.00 - equivalent to -0.03 per share.
| Operating Cash Flow | -674,670.00 |
| Capital Expenditures | -272,616.00 |
| Free Cash Flow | -947,286.00 |
| FCF Per Share | -0.03 |
Goodbody Health Limited operates with a gross margin of 49.13, reflecting its pricing power and cost economics. The operating margin of -11.44 and net profit margin of -22.61 provide insight into operational efficiency.
| Gross Margin | 49.13 |
| Operating Margin | -11.44 |
| Pretax Margin | -22.20 |
| Profit Margin | -22.61 |
| EBITDA Margin | -7.42 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 54.97 |
| FCF Yield | -79.60 |
Goodbody Health Limited's most recent stock split took place on August 22, 2022 with a 10:1 split ratio.
| Last Split Date | 8/22/2022 |
| Split Ratio | 10:1 |
Goodbody Health Limited posts an Altman Z-Score of -0.98, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.98 |